ARS Pharmaceuticals (SPRY)
Maker of the first FDA-approved needle-free nasal spray for severe allergic reactions.
$4.48
vs last close+0.13 (+2.87%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 48 days
EPS estimate
−$0.33
Revenue estimate
$42.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.52−$0.35−$0.46−$0.52−$0.42−$0.61−$0.63Pending
Estimate−$0.04−$0.35−$0.41−$0.45−$0.42−$0.53−$0.48−$0.33
Surprise+1,400.0%0.0%−12.2%−15.6%0.0%−15.1%−31.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$86.6M$8.0M$15.7M$32.5M$28.1M$22.7M$33.7MPending
Estimate$12.8M$14.7M$27.7M$25.6M$25.6M$22.2M$31.3M$42.8M
Surprise+574.4%−45.8%−43.2%+27.0%+9.7%+2.2%+7.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.01 | — | — |
| Sep 2028 | $0.20 | — | — |
| Jun 2028 | −$0.06 | — | — |
| Mar 2028 | −$0.31 | — | — |
| Dec 2027 | −$0.18 | — | — |
| Sep 2027 | −$0.10 | — | — |
| Jun 2027 | −$0.23 | — | — |
| Mar 2027 | −$0.32 | — | — |
| Dec 2026 | −$0.29 | — | — |
| Nov 2026 | −$0.33 | — | — |
| Aug 2026 | −$0.48 | −$0.63 | −31.9% |
| May 2026 | −$0.53 | −$0.61 | −15.1% |
| Mar 2026 | −$0.42 | −$0.42 | 0.0% |
| Nov 2025 | −$0.45 | −$0.52 | −15.6% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Mar 2020 | |||
| Dec 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.01 | — | — | $85.0M | — | — | — |
| Sep 2028 | $0.20 | — | — | $120.4M | — | — | — |
| Jun 2028 | −$0.06 | — | — | $81.9M | — | — | — |
| Mar 2028 | −$0.31 | — | — | $51.7M | — | — | — |
| Dec 2027 | −$0.18 | — | — | $69.4M | — | — | — |
| Sep 2027 | −$0.10 | — | — | $64.1M | — | — | — |
| Jun 2027 | −$0.23 | — | — | $44.9M | — | — | — |
| Mar 2027 | −$0.32 | — | — | $42.9M | — | — | — |
| Dec 2026 | −$0.29 | — | — | $30.8M | — | — | — |
| Nov 9, 2026 | −$0.33 | — | — | $42.8M | — | — | — |
| Aug 13, 2026 | −$0.48 | −$0.63 | −31.9% | $31.3M | $33.7M | +7.5% | −7.4% |
| May 15, 2026 | −$0.53 | −$0.61 | −15.1% | $22.2M | $22.7M | +2.2% | −6.4% |
| Mar 9, 2026 | −$0.42 | −$0.42 | 0.0% | $25.6M | $28.1M | +9.7% | −0.1% |
| Nov 10, 2025 | −$0.45 | −$0.52 | −15.6% | $25.6M | $32.5M | +27.0% | +0.3% |
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 29, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 |